Deutsche Bank
AGRX

Deutsche Bank’s Agile Therapeutics AGRX Stock Holding History

Deutsche Bank’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24
Closed -$99K – 4887
2021
Q1 		$99K Sell
24
-2
-8% -$10.8K ﹤0.01% 3990
2020
Q4 		$148K Buy
26
+7
+37% +$41.2K ﹤0.01% 3632
2020
Q3 		$115K Sell
19
-21
-53% -$120K ﹤0.01% 3489
2020
Q2 		$225K Buy
+40
New +$208K ﹤0.01% 3088
2020
Q1 		– Sell
-33
Closed -$164K – 4990
2019
Q4 		$164K Buy
+33
New +$115K ﹤0.01% 3341
2018
Q3 		– Sell
-55
Closed -$55K – 5620
2018
Q2 		$55K Buy
55
+54
+5,400% +$189K ﹤0.01% 4756
2018
Q1 		$3K Sell
1
-11
-92% -$72.7K ﹤0.01% 5290
2017
Q4 		$66K Buy
12
+3
+33% +$27.9K ﹤0.01% 4368
2017
Q3 		$80K Sell
9
-3
-25% -$23K ﹤0.01% 4238
2017
Q2 		$88K Sell
12
-3
-20% -$20.8K ﹤0.01% 4237
2017
Q1 		$94K Buy
15
+11
+275% +$55.3K ﹤0.01% 3942
2016
Q4 		$41K Buy
4
+3
+300% +$42K ﹤0.01% 4406
2016
Q3 		$14K Hold
1
– – ﹤0.01% 4619
2016
Q2 		$15K Hold
1
– – ﹤0.01% 4834
2016
Q1 		$12K Hold
1
– – ﹤0.01% 4786
2015
Q4 		$24K Hold
1
– – ﹤0.01% 4705
2015
Q3 		$19K Sell
1
-3
-75% -$53.3K ﹤0.01% 4798
2015
Q2 		$65K Hold
4
– – ﹤0.01% 4470
2015
Q1 		$73K Buy
+4
New +$70.1K ﹤0.01% 4258
2014
Q4 		– Sell
-4
Closed -$50.8K – 6026
2014
Q3 		$60K Sell
4
-14
-78% -$216K ﹤0.01% 4764
2014
Q2 		$321K Buy
+18
New +$260K ﹤0.01% 3802

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's AGRX Position: Q2 2021 in Review

Deutsche Bank sold out of Agile Therapeutics (AGRX) in Q2 2021, closing a stake of 24 shares — an estimated $99K sold.

Deutsche Bank first reported a position in AGRX in Q2 2014 and held it in 21 quarters. The position peaked at $321K in Q2 2014. 64 funds tracked by Wall St. Rank hold AGRX as of Q2 2021.

  • Deutsche Bank reported no remaining Agile Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 24 Agile Therapeutics shares in Q2 2021, an estimated $99K.
  • Deutsche Bank first reported a position in Agile Therapeutics in Q2 2014 and held it in 21 quarters.
  • Deutsche Bank's Agile Therapeutics position peaked at $321K in Q2 2014.
  • 64 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.